In the realm of neuroscience, the discovery of a neurotransmitter's role in cognition is a significant breakthrough. The recent study, published in Nature Communications, delves into the impact of histamine on memory formation, working memory, and reinforcement learning in healthy adults. While histamine has been known to play a role in memory and learning, this study provides a comprehensive understanding of its effects on human cognition. The research, led by Colwell et al. (2026), reveals that increasing histamine levels can enhance memory retrieval, support adaptive decision-making, and stabilize learning from aversive experiences. This finding has profound implications for the development of cognitive therapies and the treatment of various neurological and psychiatric disorders.
One of the most intriguing aspects of this study is the use of pitolisant, an inverse agonist of the histamine H3 receptor, to modulate histamine signaling. The researchers administered a single dose of pitolisant to 58 healthy participants and observed significant changes in their cognitive performance. During the resting period after initial learning, machine-learning analyses distinguished between participants receiving pitolisant and those receiving a placebo with 88.5% accuracy. This difference was associated with enhanced connectivity between the hippocampus and the mammillary zone, regions closely linked to memory and histamine signaling. The findings suggest that histamine modifies offline brain activity that supports memory consolidation.
The study also revealed that histamine enhances memory networks during subsequent learning of new images. Participants receiving pitolisant showed greater activation in bilateral hippocampal subregions, the basal forebrain, entorhinal cortex, and perirhinal cortex. Prolonged persistence of activity in the left medial entorhinal cortex was also observed, which is thought to support consolidation by keeping newly learned information active after it has been acquired. Memory recognition performance improved substantially in the pitolisant group, with participants identifying previously learned images more accurately and making decisions more quickly.
In the working memory task, pitolisant increased overall accuracy and drift rate, reflecting more efficient evidence accumulation during decision-making. Non-decision time increased with task complexity, suggesting an adaptive shift in pre-decisional processing under higher cognitive load. Neuroimaging results demonstrated increased activation in the left dorsolateral prefrontal cortex, and a positive correlation between dorsolateral prefrontal cortex activity and drift rate was observed.
The study also found that histamine plays a crucial role in reinforcement learning. Pitolisant improved the overall selection of optimal choices, with the most prominent effect occurring during loss-related learning. Participants receiving pitolisant showed reduced learning rates when processing aversive outcomes, which is advantageous in stable environments as it prevents excessive reactions to individual negative events and promotes more consistent decision-making. The lower learning rates associated with higher task performance indicate that histamine provides stability in value updating rather than making individuals overly reactive to losses.
The implications of this study are far-reaching. By increasing histamine signaling through histamine H3 receptor blockade, researchers observed enhanced memory encoding, neural markers consistent with memory consolidation, improved recognition performance, more efficient working memory processing, and more stable learning from negative outcomes. These findings identify histamine as an important regulator of neurocomputational processes and suggest that histamine-based therapies warrant further investigation for conditions characterized by cognitive impairment, including neurodegenerative and psychiatric disorders.
In my opinion, this study highlights the importance of histamine in human learning and cognition. The findings provide a new perspective on the role of histamine in memory and learning, and the potential for histamine-based therapies is exciting. However, further research is needed to clarify the mechanisms underlying these effects and to explore the potential of histamine-based therapies for various neurological and psychiatric disorders. Personally, I think that this study opens up new avenues for the development of cognitive therapies and the treatment of cognitive impairment, and I am eager to see how future research will build upon these findings.
